Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of ibuprofen hydrochloride spray vs celecoxib in knee osteoarthritis
ChiCTR2200058374Phase 3Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ibuprofen in knee osteoarthritis (OA) (3 arms), sponsored by Peking Union Medical College Hospital. Primary endpoints: WOMAC score (overall), VAS pain score (acute response) and 1 more. Started Sep 2021; status: recruiting.
02
Drugs
ibuprofen
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2200058374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200058374.